Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Candesartan

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 720Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Atacand

    02 2Atacand

    03 3Candesartan

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2020 Revenue in Millions : 243

    2019 Revenue in Millions : 221

    Growth (%) : 10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2021 Revenue in Millions : 97

    2020 Revenue in Millions : 243

    Growth (%) : -60

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Antihypertensives

    Currency : USD

    2015 Revenue in Millions : 501

    2014 Revenue in Millions : 358

    Growth (%) : -29%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2017 Revenue in Millions : 300

    2016 Revenue in Millions : 315

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Antihypertensives

    Currency : USD

    2014 Revenue in Millions : -18.00%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2018 Revenue in Millions : 260

    2017 Revenue in Millions : 300

    Growth (%) : -13%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2016 Revenue in Millions : 315

    2015 Revenue in Millions : 358

    Growth (%) : -12

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Atacand

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Atacand

    United Kingdom
    arrow
    euroPLX 86 Munich
    Not Confirmed

    AstraZeneca

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2019 Revenue in Millions : 221

    2018 Revenue in Millions : 260

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Candesartan

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Candesartan

    Japan
    arrow
    euroPLX 86 Munich
    Not Confirmed

    Takeda

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2016 Revenue in Millions : 408

    2015 Revenue in Millions : 819

    Growth (%) : -50

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Candesartan

    Candesartan

    arrow
    euroPLX 86 Munich
    Not Confirmed

    Brand Name : Candesartan

    Japan
    arrow
    euroPLX 86 Munich
    Not Confirmed

    Takeda

    Candesartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2017 Revenue in Millions : 235

    2016 Revenue in Millions : 435

    Growth (%) : -46

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF